Filana Therapeutics, Inc. FLNA

US Pharmaceuticals

$0.48 ▼ -2.11% ($-0.01)

Open $0.51

Prev Close $0.49

Day Range $0.48 – $0.51

52W Range $0.43 – $2.27

Market Cap $24.75M

Beta 2.01

EPS (TTM) $-0.88

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2000-07-14
Shares Out.	48,310,000
Website	filanatx.com ↗
Phone	13026587581
Employees	20
Revenue	$0
Gross Profit	$0
Net Income	-$10.7M
Free Cash Flow	-$29.1M
Total Assets	$100.1M
Total Liabilities	$42.1M
Equity	$58.0M

About Filana Therapeutics, Inc.

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Filana Therapeutics, Inc. is a publicly traded company under the ticker symbol FLNA on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.